Table 2.
Baseline | |||
n† | Missing‡ | Elevated CRP (%) | |
Total | 59 | 9 | 12 (20%) |
Abdominal | 26 | 4 | 4 (15%) |
Non-abdominal | 33 | 5 | 8 (24%) |
< 5 h | |||
---|---|---|---|
n | Missing | Elevated (%) | |
Total | 63 | 5 | 18 (29%) |
Abdominal | 29 | 1 | 8 (28%) |
Non-abdominal | 34 | 4 | 10 (29%) |
Day 1 | |||
---|---|---|---|
n | Missing | Elevated (%) | |
Total | 60§ | 6 | 23 (38%) |
Abdominal | 27 | 2 | 14 (52%) |
Non-abdominal | 33 | 4 | 9 (27%) |
Day 7 | |||
---|---|---|---|
n | Missing | Elevated (%) | |
Total | 38 | 30 | 10 (26%) |
Abdominal | 19 | 11 | 6 (32%) |
Non-abdominal | 19 | 19 | 4 (21%) |
Day 22 | |||
---|---|---|---|
n | Missing | Elevated (%) | |
Total | 53¶ | 14 | 15 (28%) |
Abdominal | 22 | 8 | 5 (23%) |
Non-abdominal | 31 | 6 | 10 (32%) |
Number of patients with available CRP level at the indicated time-point;
number of patients with no CRP value at the indicated time-point;
two CRP values excluded because of drug reactions;
one CRP value excluded because of tonsillitis in the patient.